{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T14:09:28Z","timestamp":1784210968645,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.heliyon.2024.e29230","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T01:02:13Z","timestamp":1712192533000},"page":"e29230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic significance of combined anti-extractable nuclear antigens antibody, anti-cardiolipin antibody and anti-\u03b22-glycoprotein 1 in systemic lupus erythematosus patients"],"prefix":"10.1016","volume":"10","author":[{"given":"Xuan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huina","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7198-7679","authenticated-orcid":false,"given":"Shanshan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingye","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e29230_bib1","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/S0140-6736(19)30237-5","article-title":"Management strategies and future directions for systemic lupus erythematosus in adults","volume":"393","author":"Durcan","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2024.e29230_bib2","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2024.e29230_bib3","doi-asserted-by":"crossref","DOI":"10.7326\/AITC202006020","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.heliyon.2024.e29230_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-073980","article-title":"Advances in the management of systemic lupus erythematosus","volume":"383","author":"Morand","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.heliyon.2024.e29230_bib5","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.heliyon.2024.e29230_bib6","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.heliyon.2024.e29230_bib7","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3389\/fimmu.2020.01047","article-title":"IgG4 autoantibodies Attenuate systemic lupus erythematosus progression by suppressing complement consumption and inflammatory cytokine production","volume":"11","author":"Pan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e29230_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196487","article-title":"Nunez-Alvarez Cet al. : disease activity, autoantibodies, and inflammatory molecules in serum and cerebrospinal fluid of patients with Systemic Lupus Erythematosus and Cognitive Dysfunction","volume":"13","author":"Duarte-Garcia","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e29230_bib9","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2024.e29230_bib10","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/jdv.15147","article-title":"Quaglino Pet al. : autoantibody profile and clinical patterns in 619 Italian patients with cutaneous lupus erythematosus","volume":"33","author":"Verdelli","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.heliyon.2024.e29230_bib11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.autrev.2010.09.005","article-title":"Clinical and laboratory aspects of Ro\/SSA-52 autoantibodies","volume":"10","author":"Defendenti","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.heliyon.2024.e29230_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7326\/0003-4819-99-1-32","article-title":"Transition from systemic lupus erythematosus to common variable hypogammaglobulinemia","volume":"99","author":"Sussman","year":"1983","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.heliyon.2024.e29230_bib13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/art.40747","article-title":"Association of blood concentrations of complement split product iC3b and serum C3 with systemic lupus erythematosus disease activity","volume":"71","author":"Kim","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.heliyon.2024.e29230_bib14","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1161\/01.CIR.94.7.1746","article-title":"Thrombogenic properties of murine anti-cardiolipin antibodies induced by beta 2 glycoprotein 1 and human immunoglobulin G antiphospholipid antibodies","volume":"94","author":"Pierangeli","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.heliyon.2024.e29230_bib15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.1398-9995.2003.00368.x","article-title":"Anti-cardiolipin antibodies in atopic dermatitis","volume":"59","author":"Wenzel","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.heliyon.2024.e29230_bib16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.psychres.2010.04.049","article-title":"Expression of anti-cardiolipin antibodies and inflammatory associated factors in patients with schizophrenia","volume":"187","author":"Chang","year":"2011","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.heliyon.2024.e29230_bib17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(07)60279-7","article-title":"Systemic lupus erythematosus","volume":"369","author":"D'Cruz","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2024.e29230_bib18","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1136\/annrheumdis-2018-213821","article-title":"Antinuclear antibody as entry criterion for classification of systemic lupus erythematosus: pitfalls and opportunities","volume":"78","author":"Willems","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.heliyon.2024.e29230_bib19","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/art.40512","article-title":"Brief report: lupus-an unrecognized leading cause of death in young females: a population-based study using nationwide death certificates, 2000-2015","volume":"70","author":"Yen","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.heliyon.2024.e29230_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1610-0387.2007.06557.x","article-title":"Diagnostic approach and treatment of cutaneous lupus erythematosus","volume":"6","author":"Sticherling","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.heliyon.2024.e29230_bib21","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/ard.48.7.594","article-title":"Immunoblotting profiles in 55 systemic lupus erythematosus sera lacking precipitating antibodies to extractable nuclear antigens","volume":"48","author":"Meyer","year":"1989","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.heliyon.2024.e29230_bib22","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1177\/0961203319868531","article-title":"Autoantibodies in SLE: prediction and the p value matrix","volume":"28","author":"Choi","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.heliyon.2024.e29230_bib23","first-page":"210","article-title":"Autoantigen microarray for high-throughput autoantibody profiling in systemic lupus erythematosus","volume":"13","author":"Zhu","year":"2015","journal-title":"Dev. Reprod. Biol."},{"key":"10.1016\/j.heliyon.2024.e29230_bib24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.autrev.2014.10.003","article-title":"A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients","volume":"14","author":"Yaniv","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.heliyon.2024.e29230_bib25","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s10067-015-2941-y","article-title":"Clinical associations of anti-Smith antibodies in PROFILE: a multi-ethnic lupus cohort","volume":"34","author":"Arroyo-Avila","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.heliyon.2024.e29230_bib26","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/BF02231577","article-title":"Anti-Sm: its predictive value in systemic lupus erythematosus","volume":"12","author":"Janwityanuchit","year":"1993","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.heliyon.2024.e29230_bib27","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4049\/jimmunol.96.3.464","article-title":"Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus","volume":"96","author":"Tan","year":"1966","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2024.e29230_bib28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10067-008-1043-5","article-title":"Anti-Ro antibody and cutaneous vasculitis in systemic lupus erythematosus","volume":"28","author":"Fukuda","year":"2009","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.heliyon.2024.e29230_bib29","article-title":"Serology of lupus erythematosus: correlation between immunopathological features and clinical aspects","volume":"2014","author":"Cozzani","year":"2014","journal-title":"Autoimmune Dis."},{"key":"10.1016\/j.heliyon.2024.e29230_bib30","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1177\/0961203314563817","article-title":"Similarities and differences between pediatric and adult patients with systemic lupus erythematosus","volume":"24","author":"Tarr","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.heliyon.2024.e29230_bib31","first-page":"184","article-title":"High-titer antinuclear antibodies, anti-SSA\/Ro antibodies and anti-nuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura","volume":"71","author":"Kurata","year":"1994","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.heliyon.2024.e29230_bib32","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/bmj.299.6713.1414","article-title":"Anticardiolipin antibody","volume":"299","author":"Hughes","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.heliyon.2024.e29230_bib33","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/0003-4819-112-9-682","article-title":"Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance","volume":"112","author":"Love","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.heliyon.2024.e29230_bib34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/ard.2007.078402","article-title":"B cell depletion therapy for patients with systemic lupus erythematosus results in a significant drop in anticardiolipin antibody titres","volume":"67","author":"Ioannou","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.heliyon.2024.e29230_bib35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/ard.49.6.387","article-title":"Clinical importance of persistence of anticardiolipin antibodies in systemic lupus erythematosus","volume":"49","author":"Ishii","year":"1990","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.heliyon.2024.e29230_bib36","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1177\/09612033211061475","article-title":"Something new about prognostic factors for lupus nephritis? A systematic review","volume":"30","author":"Rodriguez-Almaraz","year":"2021","journal-title":"Lupus"},{"key":"10.1016\/j.heliyon.2024.e29230_bib37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/qjmed\/91.6.401","article-title":"Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis","volume":"91","author":"Bhandari","year":"1998","journal-title":"QJM"},{"key":"10.1016\/j.heliyon.2024.e29230_bib38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0198-8859(02)00789-9","article-title":"Galluzzo Set al. : antibodies to anionic phospholipids and anti-beta2-GPI: association with thrombosis and thrombocytopenia in systemic lupus erythematosus","volume":"64","author":"Amoroso","year":"2003","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.heliyon.2024.e29230_bib39","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/jth.15082","article-title":"Antiphospholipid syndrome: complement activation, complement gene mutations, and therapeutic implications","volume":"19","author":"Chaturvedi","year":"2021","journal-title":"J. Thromb. Haemostasis"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024052617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024052617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:26:35Z","timestamp":1784208395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024052617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2405844024052617"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29230","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic significance of combined anti-extractable nuclear antigens antibody, anti-cardiolipin antibody and anti-\u03b22-glycoprotein 1 in systemic lupus erythematosus patients","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29230","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e29230"}}